American Diabetes Association
Browse
DOCUMENT
Figure_S1_A-L.pdf (903.01 kB)
DOCUMENT
Figure_S2_A-K.pdf (319.02 kB)
DATASET
Table_S1.xlsx (11.14 kB)
DATASET
Table_S2.xlsx (255.9 kB)
DATASET
Table_S3.xlsx (45.98 kB)
DATASET
Table_S4.xlsx (224.24 kB)
DATASET
Table_S5.xlsx (12.55 kB)
DATASET
Table_S6.xlsx (98.91 kB)
DATASET
Table_S7.xlsx (57.57 kB)
DATASET
Table_S8.xlsx (13.07 kB)
DATASET
Table_S9.xlsx (668.8 kB)
DATASET
Table_S10.xlsx (605.3 kB)
DATASET
Table_S11.xlsx (21.86 kB)
DATASET
Table_S12.xlsx (15.04 kB)
DATASET
Table_S13.xlsx (12.17 kB)
1/0
15 files

Connecting Genomics and Proteomics to Identify Protein Biomarkers for Adult and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

figure
posted on 2022-03-02, 15:55 authored by Faegheh Ghanbari, Nahid Yazdanpanah, Mojgan Yazdanpanah, J. Brent Richards, Despoina Manousaki
Type 2 diabetes shows an increasing prevalence in both adults and children. Identification of biomarkers for both youth and adult-onset type 2 diabetes is crucial for development of screening tools or drug targets. Here, using two-sample Mendelian randomization (MR), we identified 22 circulating proteins causally linked to adult type 2 diabetes and 11 proteins with suggestive evidence for association with youth-onset type 2 diabetes. Among these, co-localization analysis further supported a role in type 2 diabetes for C-type Mannose Receptor 2 (MR OR=0.85, 95% CI 0.79 – 0.92 per genetically predicted standard deviation (SD) increase in protein level), MANS domain containing 4 (MR OR=0.90, 95% CI 0.88 – 0.92), Sodium/potassium-transporting ATPase subunit Beta-2 (MR OR=1.10, 95% CI 1.06 – 1.15), Endoplasmic Reticulum Oxidoreductase 1 Beta (MR OR=1.09, 95% CI 1.05 – 1.14), Spermatogenesis-Associated Protein 20 (MR OR=1.12, 95% CI 1.06 – 1.18), Haptoglobin (MR OR=0.96, 95% CI 0.94 – 0.98), and Alpha 1-3-N-Acetylgalactosaminyltransferase and Alpha 1-3-Galactosyltransferase (MR OR=1.04, 95% CI 1.03 – 1.05). Our findings support a causal role in type 2 diabetes for a set of circulating proteins, which represent promising type 2 diabetes drug targets.

Funding

Pediatric Endocrine Society (PES) Clinical Scholar

History